Discover how integrated development and manufacturing can reduce risk, speed timelines, and support seamless progression from early development to commercial production.
Modern sterile manufacturing requires quality risk management. Robust contamination control across facilities, processes, and supply chains supports compliance and patient safety.
We aren't just a CDMO for standard antibodies, we also specialize in taking on the complex molecules (bispecifics, trispecifics, FC-fusions, and more).
Streamline microbial development by integrating strain engineering, process development, and fill-and-finish under one framework to eliminate technical handoffs and accelerate timelines.
Fluorescent mRNA reporters enable rapid visual confirmation of delivery and expression in mammalian cells, with bright signal, transient expression, and quantitative readouts.
A unified global model streamlines biologics from discovery to commercial supply, integrating development, manufacturing, advanced modalities, and flexible partnerships worldwide.
Integrated culture and fermentation systems streamline development, improve scalability, and strengthen continuity throughout the lifecycle of complex biopharmaceutical programs.
We’ve helped develop and commercialize multiple particle engineering based drug delivery platforms and supported development and commercialization of drug products.
Scaling mammalian biologics relies on mirrored infrastructure and single-use technologies to streamline tech transfer and enable cost-efficient commercialization.
